Case Report
Copyright ©The Author(s) 2022.
World J Clin Cases. Nov 16, 2022; 10(32): 11908-11920
Published online Nov 16, 2022. doi: 10.12998/wjcc.v10.i32.11908
Table 1 Selected literature review of rice bodies for comparison of outcomes reported

Numbers
Percent
Gender
Male3760.7
Female2439.3
Involved site
Flexor tendon sheath5895.1
Extensor tendon sheath34.90
Pathogenesis
TB2134.4
NTM1524.6
Idiopathic tenosynovitis1931.1
Other reasons69.8
ESR
Normal1321.3
High1423.0
ND3455.7
CRP
Normal2134.4
High46.60
ND3659.0
CTS
Negative1423.0
Positive1524.5
ND3252.5
Surgical treatment
Yes6098.4
No11.6
Recurrence
Yes1016.4
No3557.4
ND1626.2
Table 2 Description of 57 rice bodies published cases
Ref.
Gender/ age (yr)
Location
Symptoms/duration
Laboratory testing
Histological findings
Pathogenesis
Surgical treatment
Duration-antibiotics
Outcome
Suso et al[18], 1988M/41Flexor tendon sheathPain, swelling, restricted ROM, CTSElevated ESR of 51 mm/hTuberculous granuloma, langerhan’s cellsTBYesI + R-9 moNo recurrence during 3 yr follow-up
Sugano et al[19], 2000M/81Flexor tendon sheathSwelling/24 moNormalgiant cell, granulomaITYesNoND
Ohtani et al[6], 2002F/54Flexor tendon sheathPain, swelling, restricted ROM/12 moNDChronic nonspecific inflammationSLEYesNoNo recurrence during 1 yr follow-up
Chau et al[20], 2003M/50Flexor tendon sheathSwelling/13 moNDGranuloma, giant cellNTMYesAnti-tuberculous chemotherapyRecurrence 5 mo later and re-operation
M/69Flexor tendon sheathSwelling/13 moNDGranuloma, giant cellNTMYesAnti-tuberculous chemotherapyNo recurrence
F/71Flexor tendon sheathPain, swelling, CTS/13 moNDGranuloma, giant cellNTMYesAnti-tuberculous chemotherapyNo recurrence
Lee et al[21], 2004M/62Flexor tendon sheathSwelling, restricted ROM/30 moNDGranulomaNTMYesBiaxinRecurrence 2 yr later and re-operation
Huang et al[22], 2005M/21Flexor tendon sheathSwelling/24 moNDGranuloma, langerhan’s cellsTBYesI + R + E-9 moNo recurrence during 9 mo follow-up
Tyllianakis et al[23], 2006F/61Flexor tendon sheathPain, swelling, restricted ROM/6 moElevated ESR of 40 mm/hChronic nonspecific inflammationITYesNoNo recurrence during 1 yr follow-up
Ergun et al[24], 2008M/32Flexor tendon sheathSwelling/4 moElevated ESR of 37 mm/hChronic nonspecific inflammationITYesNoNo recurrence during 2 yr follow-up
Teo et al[25], 2008F/49Flexor tendon sheathPain, swelling, restricted ROM/7 moElevated ESR of 36 mm/hCaseous necrosisTBYesNoND
Nagasawa et al[26], 2009M/68Flexor tendon sheathPain, swelling, restricted ROM/1 moNormalChronic nonspecific inflammationITYesNoNo recurrence during 5 yr follow-up
Sanal et al[27], 2009M/22Flexor tendon sheathPain, swelling/30 moNDNDNTMYesTetracyclineND
Hung et al[28], 2011F/56Flexor tendon sheathPain, swelling/60 moNormalGranulomaTBYesAnti-tuberculous chemotherapy for 3 moNo recurrence during 1 yr follow-up
Iyengar et al[29], 2011F/72Flexor tendon sheathPain, swelling, restricted ROM, CTS/6 moElevated ESR of 50 mm/hFibrinoid necrosisSerum-negative RAYesNoRecurrence 5 mo later and re-operation
Woon et al[30], 2011M/87Flexor tendon sheathSwelling/14 moNDGranulomaTBYesAnti-tuberculous chemotherapyNo recurrence during 4 yr follow-up
M/70Flexor tendon sheathSwelling/14 monthsNDGranulomaTBYesAnti-tuberculous chemotherapyNo recurrence during 4 yr follow-up
F/30Flexor tendon sheathPain, swelling, restricted ROM, CTS/14 moNDTuberculous granuloma, multinucleate giant cellTBYesAnti-tuberculous chemotherapyNo recurrence during 4 yr follow-up
M/44Flexor tendon sheathSwelling/14 moNDEpithelioid granuloma, multinucleate giant cellTBYesAnti-tuberculous chemotherapyNo recurrence during 4 yr follow-up
F/24Flexor tendon sheathSwelling/14 moNDEpithelioid granuloma, multinucleate giant cell, central caseationTBYesAnti-tuberculous chemotherapyNo recurrence during 4 yr follow-up
F/70Flexor tendon sheathPain, swelling, restricted ROM, CTS/14 moNDGranuloma, central caseationTBYesAnti-tuberculous chemotherapyNo recurrence during 4 yr follow-up
Chavan et al[31], 2012M/57Flexor tendon sheathPain, swelling/36 moElevated ESR of 45 mm/hGranuloma, caseous necrosisTBYesAnti-tuberculous chemotherapyND
Catherine et al[32], 2012M/51Flexor tendon sheathPain, swelling, restricted ROM, CTS/24 moNormalGranulomaITYesNoNo recurrence during 1 yr follow-up
Chan et al[33], 2014M/76Flexor tendon sheathPain, swelling, restricted ROM/12 moElevated ESR of 48 mm/h and CRP of 22.5 mg/LChronic nonspecific inflammationNTMYesCAM + R + E-2 moNo recurrence during 1.5 yr follow-up
De Groote et al[34], 2014M/69Flexor tendon sheathPain, swelling, restricted ROMNDNDRAYesNoND
Hong et al[35], 2015M/80Flexor tendon sheathSwelling/36 moNormalChronic nonspecific inflammationITYesNoNo recurrence during 1 yr follow-up
Weber et al[36], 2015M/66Flexor tendon sheathPain, swelling, restricted ROM/6 moElevated CRP of 16 mg/LGranuloma, giant cellTBYesI + R-7 mo, P + E-1 moNo recurrence during 7 mo follow-up
Bayram et al[37], 2016M/50Flexor tendon sheathPain, swelling, restricted ROM/24 moElevated ESR of 24 mm/h and CRP of 18 mg/LGranulomaTBYesAnti-tuberculous chemotherapy for 12 moRecurrence 6 mo later and re-operation
Sbai et al[38], 2016M/45Extensor tendon sheathPain, swelling/6 moElevated ESR of 50 mm/hGiant cell, granuloma, caseous necrosisTBYesE + P-2 mo, I + R-8 moNo recurrence during 2 yr follow-up
Sulaiman et al[39], 2016F/71Extensor tendon sheathSwelling, restricted ROM/36 moNDNDNTMYesAnti-tuberculous chemotherapy and azithromycin for 9 moNo recurrence during 9 mo follow-up
Namkoong et al[40], 2016M/76Flexor tendon sheathTendernerss, swelling/2 moNDGranulomaNTMYesAnti-tuberculous chemotherapyRecurrence 12 mo later and re-operation
Nabet et al[41], 2017M/3Flexor tendon sheathpain, swelling, restricted ROM/2 moNormalChronic nonspecific inflammationJIAYesNSAID-14 moNo recurrence during 2.5 yr follow-up
Yamamoto et al[42], 2017M/70Flexor tendon sheathNDNDNDITYesNoND
M/70Flexor tendon sheathNDNDGranulomaNTMYesAnti-tuberculous chemotherapyRecurrence and re-operation of 2 times during 37 mo follow-up
M/53Flexor tendon sheathNDNDGranulomaTBYesAnti-tuberculous chemotherapyRecurrence 14 mo later and re-operation
M/63Flexor tendon sheathNDNDGranulomaTBYesAnti-tuberculous chemotherapy for 12 moND during 1 yr follow-up
F/83Flexor tendon sheathNDNDFibrin depositionCandidaYesAnti-tuberculous chemotherapy and CAMRecurrence 4 mo later and re-operation
F/73Flexor tendon sheathNDNDGranulomaNTMYesF-8 moNo recurrence during 8 mo follow-up
M/90Flexor tendon sheathNDNDGranulomaNTMYesF + CAM + ENo recurrence during 6 mo follow-up
F/77Flexor tendon sheathNDNDGranulomaNTMYesF + CAM + ENo recurrence during 1 yr follow-up
F/80Flexor tendon sheathNDNDGranulomaITYesF + CAM + ENo recurrence during 6 mo follow-up
Baidoo et al[43], 2018F/65Flexor tendon sheathpain, swelling, restricted ROM, CTS/24 moElevated ESR of 94 mm/hGranuloma, langerhan’s cellsTBYesE + P-3 mo, I + R-9 moNo recurrence during 1 yr follow-up
Celikyay et al[44], 2018M/34Flexor tendon sheathNDNDGranuloma, caseous necrosisTBYesNoND
Gupta et al[11], 2018F/50Flexor tendon sheathPain, swelling, restricted ROM/9 moElevated ESR of 50 mm/hNDTBNoAnti-tuberculous chemotherapy for 6 moNo recurrence during 6 mo follow-up
Hashimoto et al[45], 2018M/79Flexor tendon sheathSwelling/3 moNDCaseous necrosis, langerhan’s cellsTBYesAnti-tuberculous chemotherapy for 2 moNo recurrence during 1 yr follow-up
Mohammed Reda et al[46], 2018M/69Flexor tendon sheathPain, swelling, CTS/24 moNormalChronic nonspecific inflammationITYesNoNo recurrence during 1 yr follow-up
Saraya et al[47], 2018F/74Flexor tendon sheathSwelling, restricted ROM/48 moElevated ESR of 35 mm/hGranulomaNTMYesR + E + CAM-6 moRecurrence 5 yr later and Remedication for 1.5 yr
Kurra et al[48], 2019F/44Extensor tendon sheathPain, swelling/12 moNDChronic nonspecific inflammationCandidaYesNoND
Matcuk et al[49], 2020F/80Flexor tendon sheathPain, swelling, restricted ROM/6 moElevated ESR of 65 mm/hChronic nonspecific inflammationNTMYesAzithromycin+ E + moxifloxacin + linezolidRecurrence 3 mo later and re-operation
Perţea et al[50], 2020F/65Flexor tendon sheathPain, swelling, restricted ROM, CTS/2 moNormalEpithelioid granuloma, langerhan’s cellsITYesNoNo recurrence during 30.4 mo follow-up
F/70Flexor tendon sheathPain, swelling, restricted ROM, CTS/4 moNormalEpithelioid granuloma, langerhan’s cellsITYesNoNo recurrence during 30.4 mo follow-up
M/56Flexor tendon sheathSwelling/24 moNormalEpithelioid granuloma, langerhan’s cellsITYesNoNo recurrence during 30.4 mo follow-up
M/47Flexor tendon sheathSwelling/48 moNormalEpithelioid granuloma, langerhan’s cellsITYesNoNo recurrence during 30.4 mo follow-up
Daoussis et al[51], 2021F/63Flexor tendon sheathNDNDNDNTMYesAnti-tuberculous chemotherapyND
Tomala et al[52], 2021F/86Flexor tendon sheathPain, swelling, restricted ROM, CTS/24 moNDChronic nonspecific inflammationITYesNoND
Zeng et al[53], 2018M/67Flexor tendon sheathPain, swelling, restricted ROM/24 moElevated CRP of 32.8 mg/LChronic nonspecific inflammationITYesNoNo recurrence
Li and Zhang et al[54], 2019M/55Flexor tendon sheathPain, swelling, restricted ROM/36 moNDChronic nonspecific inflammationITYesNoNo recurrence during 3 mo follow-up
Cheng et al[55], 2020M/41Flexor tendon sheathPain, swelling, restricted ROM, CTS/0.5 moElevated ESR of 17 mm/hNDITYesNoND
Liang et al[56], 2020F/45Flexor tendon sheathPain, swelling, restricted ROM, CTS/24 moNormalChronic nonspecific inflammationITYesNoNo recurrence during 1 yr follow-up
Liu et al[57], 2021M/56Flexor tendon sheathPain, swelling, CTS/24 moNDProminent acidophilic, amorphous necrotic areasITYesNoND
Korkmaz et al[58], 2021M/42Flexor tendon sheathPain, swelling/24 moNormalGranulomatous lesions with central necrosisTBYesAnti-tuberculous chemotherapyNo recurrence during 4 mo follow-up